KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Short term Debt (2016 - 2025)

Historic Short term Debt for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $2.8 billion.

  • Gilead Sciences' Short term Debt rose 5485.65% to $2.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year increase of 5485.65%. This contributed to the annual value of $1.8 billion for FY2024, which is 94.55% up from last year.
  • Latest data reveals that Gilead Sciences reported Short term Debt of $2.8 billion as of Q3 2025, which was up 5485.65% from $2.8 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Short term Debt registered a high of $4.0 billion during Q2 2023, and its lowest value of $1.0 billion during Q2 2022.
  • For the 5-year period, Gilead Sciences' Short term Debt averaged around $2.2 billion, with its median value being $2.3 billion (2021).
  • Per our database at Business Quant, Gilead Sciences' Short term Debt surged by 29539.67% in 2023 and then plummeted by 5516.47% in 2024.
  • Over the past 5 years, Gilead Sciences' Short term Debt (Quarter) stood at $1.5 billion in 2021, then soared by 49.93% to $2.3 billion in 2022, then decreased by 20.9% to $1.8 billion in 2023, then grew by 0.95% to $1.8 billion in 2024, then soared by 54.6% to $2.8 billion in 2025.
  • Its last three reported values are $2.8 billion in Q3 2025, $2.8 billion for Q2 2025, and $2.8 billion during Q1 2025.